This will save lives. The groundbreaking results from Australia’s first injectable opioid treatment (FOpIT) trial are in, offering powerful new hope. This is a new, evidence-based pathway for people with opioid dependence, a group for whom standard treatments sometimes aren't enough. Why is this so important? Opioids are the single most common drug type in unintentional overdose deaths, contributing to nearly half of all such deaths in 2023. The trial was a partnership between Uniting NSW.ACT, St Vincent’s Hospital, and UNSW, and the outcomes showed that this new treatment is both safe and feasible. It is a proven, health-based solution that offers new hope where punitive policies have failed. Best of all, it received "near universal praise" from participants, who described the programme as a "godsend." #PublicHealth #HarmReduction #OverdosePrevention #OpioidCrisis #AustralianHealth #UNSW #StVincents #Uniting #NewHope UNSW UNSW Medicine & Health St Vincent's Health Australia St Vincent's Hospital Sydney undefined Andrew Bradley Marianne Jauncey Emma Maiden
Australia's first injectable opioid treatment trial yields promising results
More Relevant Posts
-
ABC Global Decade Report 2015 - 2025: How far have we come? Goal 1: Improving overall survival of patients living with #advancedbreastcancer "This decade has seen a revolution in care" - Mariana Chavez-Macgregor, US 💊 17 new drugs approved in the US in the past decade 🌎 5yr survival has improved from 26% to 33%, but this is not distributed equally across all regions. 🤒 Longer survival brings challenges of toxicity and life impact. In the next decade, we need to improve overall survival across all subtypes and reduce disparities across the globe. #ABCLisbon #ABC8 #advancedBC #Goal1
To view or add a comment, sign in
-
A new systematic review and meta-analysis suggests ibogaine could offer meaningful relief from opioid withdrawal and improve long-term recovery outcomes. While evidence remains limited, researchers say it highlights an urgent need for clinical trials to confirm its safety and efficacy. Read more here: https://lnkd.in/eftWMSRB #AddictionMedicine #OpioidUseDisorder #PublicHealth
To view or add a comment, sign in
-
-
A new review from the Hebrew University reveals decades of overlooked suicide risk linked to finasteride, a common hair-loss drug. Despite mounting evidence of depression and suicidality, regulators and manufacturers failed to act adequately. It’s time to prioritise patient safety and reform drug monitoring. Read more: https://ow.ly/lWvB50XpTGP #PublicHealth #DrugSafety #MensMentalHealth #MentalHealth
To view or add a comment, sign in
-
-
🎙️ In today’s news https://lnkd.in/epS2jdQn : - The #FDA has steadied the ship at #CDER by naming veteran regulator #RichardPazdur as director, although he was reportedly reluctant to take the job. - UK Health Secretary #WesStreeting has given the green light to a series of #NHSreforms that will see around 18,000 administrative #rolesabolished. - The #UKgovernment has set out an ambitious plan to phase out #animaltesting in #scientificstudies within five years. - Bayer's #Q3 sales came in a bit higher than anticipated, but the company is girding its loins for a challenging period ahead. - Alkermes' alixorexton is the first #orexin2receptoragonist to show efficacy in phase 2 trials involving patients with both main #narcolepsy subtypes. - #OneDrop founder Jeffrey Dachis brought his new product out of stealth mode at Frontiers Health - a #CGM for use beyond Type 1 diabetes.
To view or add a comment, sign in
-
A new review by a public health expert from the Hebrew University of Jerusalem reveals that finasteride, a common hair-loss drug, has been linked to depression and suicide for over two decades — yet regulators and manufacturers failed to act. Drawing on data from adverse event reports and healthcare records around the world, the study shows consistent psychiatric harm associated with the drug. Despite mounting evidence, neither Merck nor the FDA initiated critical safety studies. The author calls for urgent reform in how medications are monitored and approved. https://lnkd.in/gQrfJG72
To view or add a comment, sign in
-
-
At eMed, our enduring mission has been to democratize access to GLP-1s, and we’re pleased to see that President Trump’s proposed GLP-1 plan aligns closely with our mission and goals. These new recommendations are crucial for ensuring that trusted, FDA-approved medications are accessible to all Americans, thereby eliminating the secondary counterfeit market. "This moment truly marks a pivotal turning point in the U.S., with obesity being recognized as one of the key drivers of chronic disease." - Dyan Hes, MD eMed will continue to collaborate with our partners to deliver the highest standard of clinical practice in obesity care, employing FDA-approved medications through our medically supervised, Empathetic AI platform. #eMed #eMedPopulationHealth #GLP1
To view or add a comment, sign in
-
-
Medication-assisted treatment with Suboxone achieves 60%+ success rates for opioid recovery, while cold turkey withdrawal maintains only 3-5% long-term sobriety. Cold turkey methods expose patients to dangerous medical complications including severe dehydration, cardiac stress, and overdose risks during inevitable relapse attempts. MAT patients receive medical supervision that eliminates withdrawal symptoms while maintaining normal daily function throughout treatment. The evidence shows MAT reduces overdose deaths by 59% and provides sustained employment rates above 70% in five-year follow-up studies, making professional medical support essential for lasting recovery success. https://lnkd.in/dcz9MTj7
To view or add a comment, sign in
-
The opioid elimination industry has been meticulous. Even with a provider willing to treat pain, the industry flags providers, preventing pharmacists from dispensing medication. This has led to a significant increase in deadly overdoses and suicides among those suffering from pain. The Doctor Patient Forum is a non-partisan, community-driven organization dedicated to supporting individuals with chronic pain/illness, as well as their healthcare providers, in accessing lifesaving pain relief. We advocate against harmful prescribing restrictions that lead to patient abandonment and forced opioid tapers. DPF provides education, research, advocacy tools, and practical resources to help patients thrive despite their diagnoses. We empower patients to navigate a complex healthcare system and live life to its fullest. https://lnkd.in/eceb6ecR
To view or add a comment, sign in
-
-
The opioid elimination industry has been meticulous. Even with a provider willing to treat pain, the industry flags providers, preventing pharmacists from dispensing medication. This has led to a significant increase in deadly overdoses and suicides among those suffering from pain. The Doctor Patient Forum is a non-partisan, community-driven organization dedicated to supporting individuals with chronic pain/illness, as well as their healthcare providers, in accessing lifesaving pain relief. We advocate against harmful prescribing restrictions that lead to patient abandonment and forced opioid tapers. DPF provides education, research, advocacy tools, and practical resources to help patients thrive despite their diagnoses. We empower patients to navigate a complex healthcare system and live life to its fullest. https://lnkd.in/eceb6ecR
To view or add a comment, sign in
-
-
Studies show that drug-overdose rates in the U.S. are approximately 22% higher during the holiday season compared to non-holiday weeks — and notably, 57% of those overdoses occurred in people who had received an opioid prescription in the past year. https://lnkd.in/gWtce9Wj #holiday #drugoverdose #overdose #individual #rates #prescription #holidayseason #month #bestvacation #beabout #season #study #studies #week #studyweek #bicx
To view or add a comment, sign in
-
National Aged Care Recruitment Partner | Delivering Talent, Supporting Providers. Talk to me about your Permanent Staffing needs in Aged Care
1wRecovery - supporting people who need help and minimisation of risk..